GT Biopharma, Inc. (GTBP)
GT Biopharma Market Cap : 14.64M for March 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 900.79M |
| Lyell Immunopharma, Inc. | 281.65M |
| ACADIA Pharmaceuticals, Inc. | 3.614B |
| Alnylam Pharmaceuticals, Inc. | 41.00B |
| Savara, Inc. | 1.040B |
Market Cap Related Metrics
| PEG Ratio | -0.0003 |
| Price to Book Value | 2.530 |
| Price | 0.4639 |
| Earnings Yield | -3.15K% |
| PEGY Ratio | -0.0003 |